Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Mon, 16.03.2026
IBU-tec advanced materials AG
Disclosure of inside information pursuant to Article 17 of Regulation (EU) 596/2014
IBU-tec advanced materials AG publishes planning: Revenue expectation of at least EUR 120-140 million in 2030 and EUR 37- 39 million for 2026
EBITDA margin is to increase to 13-15 percent by 2030 after an expected 7- 10 percent EBITDA margin in 2026
Revenu [ … ]
Mon, 16.03.2026
Wolford AG
Wolford AG reports revenues of €76 million for fiscal year 2025, representing a 14% decrease compared to the prior year (€88 million in 2024).
The performance in the first half of 2025 was significantly affected by the tail end of prior‑year challenges and the ongoing transition phase—including macroeconomic uncertainties and logistical disruptions [ … ]
Mon, 16.03.2026
CoinShares Digital Securities Limited
16 March 2026
CoinShares Digital Securities Limited
Exchange Traded Products Programme for the issue of
CoinShares Digital Securities
LEI: 549300DR7967WVLR3P83
CoinShares Polkadot Staking ETP Securities - Sharing of Staking Rewards
Jersey - 16 March 2026 - CoinShares Digital Securities Limited (the "Issuer") hereby announces in ac [ … ]
Mon, 16.03.2026
UBS AG
.awlist1_1773640389_710588 { list-style:none; counter-set:awlistcounter1 }
.awlist1_1773640389_710588 li:before { content:'6.' counter(awlistcounter1) '.'; counter-increment:awlistcounter1 }
.awlist2_1773640389_710588 { list-style:none; counter-set:awlistcounter2 }
.awlist2_1773640389_710588 li:before { content:'7.' counter(awlistcounter2) [ … ]
Mon, 16.03.2026
BioVersys AG
Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland. March 16, 2026, 7am CET
BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP), caused by carbapenem-resistant Acinetobacter baumannii (CRAB).
US FDA [ … ]
Fri, 13.03.2026
Enapter AG
Publication of Inside Information pursuant to Article 17 of Regulation (EU) No. 596/2014
Enapter AG Publishes Preliminary Figures for 2025
Hamburg, March 13, 2026. Enapter AG (ISIN: DE000A255G02) announces its preliminary, unaudited figures for 2025. Revenue amounted to approximately 22.1 million euros, which is within the previously communicate [ … ]
Fri, 13.03.2026
Liechtensteinische Landesbank / LLB
Vaduz, 13 March 2026. The LLB Group has published its complete Annual Report 2025. It contains comprehensive information concerning financial and non-financial aspects of the 2025 business year. In addition, the documents for the 34th ordinary General Meeting of Shareholders are dispatched.
The annual report for 2025 focuses on the successful furth [ … ]
Thu, 12.03.2026
Dexus Finance Pty Limited
Dexus (ASX: DXS)
ASX release
13 March 2026
Appendix 3C
Dexus today announced an Appendix 3C – Notice of Buy Back – daily trade notification.
The ASX release is available to download at www.dexus.com/dxs.
Authorised by Brett Cameron, General Counsel and Company Secretary of Dexus Funds Management Limited
For further information please contac [ … ]
Thu, 12.03.2026
Amrize Ltd
CHICAGO/ZUG, March 12, 2026 – Amrize (AMRZ) has published its Annual General Meeting (AGM) Invitation, Proxy Statement and Annual Report for Fiscal Year 2025.
Amrize’s Annual General Meeting will take place at the Theater Casino Zug, Artherstrasse 4, 6300 Zug, Switzerland on April 21, 2026 at 09:00 am CEST; doors open at 08:00 am CEST.
The docume [ … ]
Thu, 12.03.2026
Swiss Re Ltd
Ad hoc announcement pursuant to Article 53 LR
Annual Report 2025 presents Swiss Re's Group strategy and its business performance and risk assessment for 2025
Annual Report now includes the Sustainability Report
Invitation to 2026 Annual General Meeting (AGM) outlines the Board of Directors' proposals for shareholder vote
Swiss Re proposes to e [ … ]
